Subscribe to RSS
DOI: 10.1055/a-2589-5900
Fused Tricyclic Naphthalene Lactones and a Xanthone from Ventilago maingayi and their Anti-HIV-1 Activity
This research has received financial support from NSRF via the Program Management Unit for Human Resources & Institutional Development, Research, and Innovation [Grant No. B16F640099]. The authors are grateful to the Center of Excellence for Innovation in Chemistry (PERCH-CIC), Ministry of Higher Education, Science, Research and Innovation, and Mahidol University for instrumental support. S. H. acknowledged the Faculty of Science and Technology, Rajabhat Rajanagarindra University. Special thanks go to Mr. Chanchai Sukkum (Rajabhat Rajanagarindra University) for constructive comments, Dr. Samran Prabpai (Faculty of Science, Mahidol University) for X-ray diffraction analysis, Dr. Rattanawalee Rattanawan (Faculty of Science, Ubon Ratchathani University) for ECD calculations, Dr. Phongthon Kanjanasirirat (Department of Pathobiology, Faculty of Science, Mahidol University) for biological calculations, and Ms. Chanita Napaswad and Ms. Jitra Limthongkul (Department of Microbiology Faculty of Science, Mahidol University) for anti-HIV assays.

Abstract
Three previously undescribed compounds, including two fused tricyclic naphthalene lactones (ventilaganones A and B, 1 and 2) and a xanthone (ventilagoxanthone, 3), along with eight known compounds (4–11), were isolated from the bark of Ventilago maingayi. Their structures were elucidated by extensive analysis of their spectroscopic data and by comparison with those of related compounds reported in the literature. The absolute configuration of ventilaganone A (1) was established by single-crystal X-ray analysis. Anti-HIV-1 activity of the isolated compounds was evaluated with a reverse transcriptase (RT) assay and a syncytium reduction assay using the ΔTat/RevMC99 virus in the 1A2 cell line. Compounds 1, 2, 4, 5, and 8–11 showed inhibitory activity against syncytium formation, while most compounds were found to be inactive in the reverse transcriptase assay.
Supporting Information
- Supporting Information
Details of the extraction and isolation procedures, preliminary biological screening data along with 1H, 13C, 2D NMR, and HR-ESI-MS spectra of compounds 1–3 are available in Supporting Information.
Publication History
Received: 28 October 2024
Accepted after revision: 16 April 2025
Accepted Manuscript online:
16 April 2025
Article published online:
08 May 2025
© 2025. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Cooke R, Johnson B. Colouring matters of Australian plants. XI. quinones from Ventilago viminalis . Aust J Chem 1963; 16: 695-702
- 2 Norsaengsri M, Chantaranothai P, Schirarend C. Rhamnaceae. In: Newman MF, Barford AS, Esser HJ, Simpson DA, Parnell JAN, eds. Flora of Thailand. Bangkok: Prachachon; 2020. 14. 551-587
- 3 Smitinand T. Thai Plant Names, Revised ed. Bangkok: Prachachon; 2014: 578
- 4 DeFilipps RA, Krupnick GA. The medicinal plants of Myanmar. PhytoKeys 2018; 102: 1-341
- 5 Hangsamai N, Photai K, Mahaamnart T, Kanokmedhakul S, Kanokmedhakul K, Senawong T, Nontakitticharoen M. Four new anthraquinones with histone deacetylase inhibitory activity from Ventilago denticulata roots. Molecules 2022; 27: 1088
- 6 Molee W, Phanumartwiwath A, Kesornpun C, Sureram S, Ngamrojanavanich N, Ingkaninan K, Kittakoop P. Naphthalene derivatives and quinones from Ventilago denticulata and their nitric oxide radical scavenging, antioxidant, cytotoxic, antibacterial, and phosphodiesterase inhibitory activities. Chem Biodivers 2018; 15: 1700537
- 7 Panthong K, Hongthong S, Kuhakarn C, Piyachaturawat P, Suksen K, Panthong A, Reutrakul V. Pyranonaphthoquinone and anthraquinone derivatives from Ventilago harmandiana and their potent anti-inflammatory activity. Phytochemistry 2020; 169: 112182
- 8 Gossan DPA, Magid AA, Yao-Kouassi PA, Le Faucheur D, Coffy AA, Harakat D, Voutquenne-Nazabadioko L. New flavonol glycoside from the leaves of Ventilago africana . Nat Prod Commun 2015; 10: 1934578X1501001103
- 9 Wang LL, Zuo JP, Ma L, Wang XC, Hu LH. Two new xanthone glycosides from Ventilago leiocarpa Benth. Nat Prod Commun 2008; 3: 1934578X0800300522
- 10 Azizah M, Pripdeevech P, Thongkongkaew T, Mahidol C, Ruchirawat S, Kittakoop P. UHPLC-ESI-QTOF-MS/MS-based molecular networking guided isolation and dereplication of antibacterial and antifungal constituents of Ventilago denticulata . Antibiotics 2020; 9: 606-640
- 11 Jariyasopit N, Limjiasahapong S, Kurilung A, Sartyoungkul S, Wisanpitayakorn P, Nuntasaen N, Kuhakarn C, Reutrakul V, Kittakoop P, Sirivatanauksorn Y, Khoomrung S. Traveling wave ion mobility-derived collision cross section database for plant specialized metabolites: An application to Ventilago harmandiana Pierre. J Proteome Res 2022; 21: 2481-2492
- 12 Ngan NTT, Quang TH, Kim KW, Kim HJ, Sohn JH, Kang DG, Oh H. Anti-inflammatory effects of secondary metabolites isolated from the marine-derived fungal strain Penicillium sp. SF-5629. Arch Pharm Res 2017; 40: 328-337
- 13 Wang Y, Zheng Z, Liu S, Zhang H, Li E, Guo L, Che Y. Oxepinochromenones, furochromenone, and their putative precursors from the endolichenic fungus Coniochaeta sp. J Nat Prod 2010; 73: 920-924
- 14 Suksamrarn S, Lomchoey N, Nontakham J, Suebsakwong P. Antiacetylcholinesterase activity of Ventilago denticulata extracts and its chemical constituents. KKU Sci J 2017; 45: 701-713
- 15 Saisin S, Panthong K, Hongthong S, Kuhakarn C, Thanasansurapong S, Chairoungdua A, Reutrakul V. Pyranonaphthoquinones and naphthoquinones from the stem bark of Ventilago harmandiana and their anti-HIV-1 activity. J Nat Prod 2023; 86: 498-507
- 16 Lin LC, Chou CJ, Kuo YC. Cytotoxic principles from Ventilago leiocarpa . J Nat Prod 2001; 64: 674-676
- 17 Liu D, Yan L, Ma L, Huang Y, Pan X, Liu W, Lv Z. Diphenyl derivatives from coastal saline soil fungus Aspergillus iizukae . Arch Pharm Res 2015; 38: 1038-1043
- 18 Hanumaiah T, Rao BK, Rao CP, Rao GSR, Rao JUM, Rao KVJ, Thomson RH. Naphthalenes and naphthoquinones from Ventilago species. Phytochemistry 1985; 24: 1811-1815
- 19 Bourhis LJ, Dolomanov OV, Gildea RJ, Howard JA, Puschmann H. The anatomy of a comprehensive constrained, restrained refinement program for the modern computing environment–Olex2 dissected. Acta Crystallogr A Found Adv 2015; 71: 59-75
- 20 Parsons S, Flack HD, Wagner T. Use of intensity quotients and differences in absolute structure refinement. Acta Crystallogr B Struct Sci Cryst Eng Mater 2013; 69: 249-259
- 21 Dolomanov OV, Bourhis LJ, Gildea RJ, Howard JA, Puschmann H. OLEX2: A complete structure solution, refinement, and analysis program. J Appl Crystallogr 2009; 42: 339-341
- 22 Tan GT, Pezzuto JM, Kinghorn AD, Hughes SH. Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J Nat Prod 1991; 54: 143-154
- 23 Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984; 22: 27-55
- 24 Kiser R, Makovsky S, Terpening SJ, Laing N, Clanton DJ. Assessment of a cytoprotection assay for the discovery and evaluation of anti-human immunodeficiency virus compounds utilizing a genetically impaired virus. J Virol Methods 1996; 58: 99-109